Semaglutide vs. Tirzepatide: Which Is Right for You?
No Author • October 2, 2026
You’ve heard both names, and now you want to know which weekly injection fits your body and your goals. This guide breaks down semaglutide vs. tirzepatide in plain terms: how each works, what the head-to-head research found, and which side effects to expect. It’s for adults weighing medical weight loss who want straight answers before a first appointment.
Short answer: In the head-to-head trial, tirzepatide produced greater average weight loss than semaglutide (20.2% vs. 13.7% at 72 weeks), but individual results vary, and the right choice depends on your health history, tolerance, and goals.
What Is Semaglutide?
Semaglutide is a once-weekly injection that mimics GLP-1, a hormone your gut releases after you eat. That hormone signals your brain about appetite, slows how quickly your stomach empties, and helps your pancreas release insulin when blood sugar rises. MedlinePlus, the National Library of Medicine’s drug information service, describes semaglutide injection as a medication that slows stomach emptying and can lower appetite.
What Is Tirzepatide?
Tirzepatide is also a once-weekly injection, but it works on two hormone pathways instead of one. It activates the GLP-1 receptor, like semaglutide, plus a second receptor, GIP, another gut hormone that affects appetite and metabolism. The authors of the head-to-head trial below call it a dual GIP and GLP-1 receptor agonist, meaning it presses two buttons where semaglutide presses one.
Semaglutide vs. Tirzepatide: How They Work and Key Differences
Both medications slow digestion and quiet appetite signals, so the day-to-day experience can feel similar. When people ask about semaglutide vs. tirzepatide, the honest answer starts underneath that: one hormone signal or two.
The trial authors suggest the dual action may help explain why weight loss ran higher with tirzepatide. That’s a hypothesis, not a proven mechanism for any one person. Providers step the dose up gradually with both. The MedlinePlus page on tirzepatide injection notes that increases come no more than once every four weeks, so the early weeks are about tolerance, not top-end results.
Tirzepatide vs. Semaglutide for Weight Loss: What the Research Shows
A head-to-head trial in adults with obesity but without type 2 diabetes, called SURMOUNT-5, was published in the New England Journal of Medicine in 2025. The trial randomly assigned 751 adults to the maximum dose each person could tolerate of either medication, injected weekly for 72 weeks.
Average body weight dropped 20.2% with tirzepatide and 13.7% with semaglutide. The table below shows how the two compared on other measures.
This is paragraph text. Click it or hit the Manage Text button to change the font, color, size, format, and more. To set up site-wide paragraph and title styles, go to Site Theme.
| In SURMOUNT-5 | Semaglutide | Tirzepatide |
|---|---|---|
| Hormone targets | GLP-1 | GLP-1 and GIP |
| Average weight change at 72 weeks | -13.7% | -20.2% |
| Average waist change | -13.0 cm | -18.4 cm |
| Stopped treatment over digestive side effects | 5.6% | 2.7% |
| Injection-site reactions | 0.3% | 8.6% |
Group averages from one trial. Individual results vary.
Tirzepatide Weight Loss Results in Context
Those figures are group averages, and some people lose more or less. The trial was open-label, meaning everyone knew which medication they received, and it was funded by the maker of tirzepatide. No participant had diabetes, so the numbers may not describe you if your health picture differs. Individual results vary, and a provider prescribes medication only after evaluating your health history.
Is Tirzepatide Stronger Than Semaglutide?
On average, yes, in that trial. People taking tirzepatide were also more likely to reach weight reductions of at least 10%, 15%, 20%, and 25%.
Stronger doesn’t automatically mean better for you. The right medication is the one your body tolerates well enough to stay on, which depends on your digestion, health history, hormones, sleep, and stress.
Tirzepatide vs. Semaglutide Side Effects Compared
Because both medications affect digestion, their side effects overlap. Common side effects of tirzepatide include nausea, vomiting, diarrhea, decreased appetite, constipation, and upset stomach.
In SURMOUNT-5, digestive problems were the most common side effects in both groups, mostly mild to moderate and mostly during dose increases. Stopping treatment over digestive side effects happened more often with semaglutide, while injection-site reactions were more common with tirzepatide, as the table above shows.
Warnings Both Share
Each medication caused thyroid tumors in rats, and it isn’t known whether they do in humans. Tell your provider if you or anyone in your family has had thyroid cancer or a condition called MEN 2, which causes tumors in more than one gland. Call right away for a lump in your neck, hoarseness, trouble swallowing, shortness of breath, or stomach pain that won’t go away.
How to Switch From Semaglutide to Tirzepatide, and When It Makes Sense
Switching usually comes up when progress stalls or side effects get in the way. SURMOUNT-5 randomized people to one medication from the start, so it can’t tell us how a switch performs.
Whether to switch is a decision you and your provider make together. A good provider looks at the dose you reached, how long you’ve been on it, how your digestion handled it, and what else could be stalling progress. Hormone shifts can be one factor, which we cover in our guide on whether hormonal imbalance can cause weight gain. Don’t stop or change medication on your own.
Who Might Be a Better Candidate for Each?
No article can assign you a medication, but a few factors shape the conversation:
- Your health history: A personal or family history of thyroid cancer or MEN 2 matters for both. Pancreatic disease, kidney disease, and stomach problems are also worth raising first.
- Your other conditions: Uses include sleep apnea in adults with obesity for tirzepatide and liver disease (MASH) for semaglutide.
- Your life stage and medications: Tirzepatide may reduce how well hormonal birth control works, and pregnancy plans matter for both. If you’re in perimenopause or menopause, your provider may look at hormone health alongside medication, because hormone changes can affect weight.
What to Expect at Rural Authentic Wellness
We serve West Central and South Central Minnesota from clinics in Olivia and Redwood Falls. Our medically supervised weight management program treats weight as a clinical issue, not a willpower test. Care starts with a full intake that includes labs and a body composition analysis. For appropriate candidates, GLP-1 options are one part of a plan that also includes nutrition counseling, exercise support, behavioral check-ins, and ongoing monitoring.
Your provider decides whether a GLP-1 medication fits you, and which one, after that evaluation. The program is direct pay, so you don’t have to wait on insurance prior authorization. It’s billed separately from your primary care membership, and members receive discounted pricing on monitoring labs. The program page lists current pricing.
Pick the Plan, Not Just the Medication
The semaglutide vs. tirzepatide question has a clear research answer on averages and a much less clear one for any individual. Tirzepatide came out ahead in the head-to-head trial, but even the stronger option on paper needs labs, follow-up, and a provider who adjusts the plan when your body surprises you.
If you’d like to talk through which option fits your health history, book a weight management consultation. We’ll walk you through what a program looks like for your situation.
Frequently Asked Questions
1. What is the difference between semaglutide and tirzepatide?
Semaglutide activates one gut hormone pathway, GLP-1. Tirzepatide activates two, GLP-1 and GIP. Both are weekly injections that slow stomach emptying and lower appetite.
2. How long does tirzepatide take to work vs. semaglutide?
Neither works overnight. Both start at a lower dose that increases over weeks. The trial measured weight change at 72 weeks, so meaningful results are tracked in months.
3. Can I take tirzepatide if semaglutide didn’t work?
Possibly, but that’s a decision to make with your provider, not a self-switch. The head-to-head trial compared people starting each medication, so it doesn’t show how a switch performs. Your provider will weigh your dose, side effects, and other factors that could be slowing progress.
4. Do I have to stay on a GLP-1 medication forever?
There’s no one-size-fits-all answer, so bring it up with your provider at the start. Semaglutide helps control weight but doesn’t cure it, and stopping without talking to your provider isn’t advised. That’s why our program pairs any medication with nutrition counseling, exercise support, and behavioral check-ins.
5. What happens at a first medical weight loss visit?
At Rural Authentic Wellness, a first visit covers your health history, current medications, metabolic labs, and a body composition analysis. We consider medication only after that evaluation, and only for appropriate candidates.
Key Takeaways
- Write down your health history before the visit, including any thyroid cancer or MEN 2 in your family, and bring your current medication list.
- Treat the trial’s weight-loss figures as group averages for framing questions, not as a forecast for your own results.
- Keep a weekly symptom log during dose increases, since digestive side effects tend to cluster there.
- Decide your top priority before you compare options, whether that’s maximum weight loss, the gentlest digestion, or the simplest routine, so the trade-offs are easy to discuss.













